IP Verse

Biomadison competitive analysis

Loading summary...

Latest patents of Biomadison opposed by its competitors

Explore Biomadison's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 23, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP3030905
Apr 3, 2024Botulinum Toxin Assay With Improved Sensitivity1
EP3270162
Aug 16, 2023Botulinum Toxin Assay With Improved Sensitivity1
EP2800973
May 16, 2018Methods And Compounds For Increasing Sensitivity Of Botulinum Assays1

Latest publications and patents of Biomadison New

Explore the latest publications and patents granted to Biomadison, showcasing their recent innovations and technological advancements.

Last updated on: Oct 21, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Biomadison

EP3030905
Apr 3, 2024Botulinum Toxin Assay With Improved SensitivityPatent Maintained As Amended
EP3270162
Aug 16, 2023Botulinum Toxin Assay With Improved SensitivityPatent Maintained As Amended
EP2800973
May 16, 2018Methods And Compounds For Increasing Sensitivity Of Botulinum AssaysRevoked

Latest PTAB cases involving Biomadison

Discover the latest PTAB cases involving Biomadison, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Biomadison with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 23, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
BIOMADISON - 3 - -
MERZ PHARMA176 - -